Rockwell Medical Reports Q3 2026 Results and Announces Vantive Limited Acquisition
Rockwell Medical (RMTI) reported third-quarter revenue of $19.1 million, a 20% year-over-year increase driven by higher purchasing volumes from major U.S. dialysis providers and expansion in the Western U.S. While gross profit rose 37% to $3.1 million with expanding margins, the company reported a net loss of $2.3 million, largely due to transaction costs related to its upcoming acquisition of Vantive Limited's global hemodialysis business. The pending acquisition is expected to close in mid-2027 and will significantly scale the company's footprint, adding machines, water treatment systems, and a manufacturing campus in Italy. Management projects that the combined entity will generate between $400 million and $450 million in annual revenue, with approximately 90% of that revenue expected to be recurring.
Tickers: $RMTI
Topics: acquisition earnings report financial results revenue growth
Read the full article at Motley Fool
Part of the story Rockwell Medical Reports Q3 2026 Results and Announces Vantive Limited Acquisition (2 articles)